லிசூ ஆரோக்கியம் ஷ்ரெவெப்போருத News Today : Breaking News, Live Updates & Top Stories | Vimarsana

LSU Health Shreveport SHREVEPORT – A team of scientists and clinicians at LSU Health Shreveport, collaborating across the Centers for Brain Health and Cardiovascular Diseases and Sciences, had their groundbreaking findings on a new blood biomarker for Alzheimer’s disease and related dementia published in the prestigious “Alzheimer’s & Dementia, The Journal of the Alzheimer’s Association”. LSUHS faculty Drs. Elizabeth Disbrow, Chris Kevil, Steve Alexander, and Karen Stokes were joined by colleagues from the Vascular Medicine Institute at the University of Pittsburg Medical Center and the Department of Computer Science at Louisiana State University in Shreveport. There is growing appreciation for the important role cerebrovascular disease plays in the development of Alzheimer’s disease and related dementias (ADRD). The newly identified plasma biomarker for ADRD, hydrogen sulfide, is already a known biomarker for cardiovascular disease. The team use

United statesChris kevilSteve alexanderElizabeth disbrowSciences of the national institutes healthCenters for brain healthInstitutional development awardNational institutesJournal of the alzheimer associationLsu health shreveportHealth shreveportVascular medicine instituteUniversity of pittsburg medical centerBrain healthCardiovascular diseasesKaren stokes